Endo International (ENDP) Tops Q1 EPS by 20c, Guidance Misses Consensus
Get Alerts ENDP Hot Sheet
Price: $0.29 --0%
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
ANAB, ANIX, MNY, More
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Endo International (NASDAQ: ENDP) reported Q1 EPS of $0.66, $0.20 better than the analyst estimate of $0.46. Revenue for the quarter came in at $652 million versus the consensus estimate of $631.07 million.
GUIDANCE:
Endo International sees Q2 2022 EPS of ($0.17)-($0.15), versus the consensus of $0.48. Endo International sees Q2 2022 revenue of $550-525 million, versus the consensus of $655.6 million.
For earnings history and earnings-related data on Endo International (ENDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share